Novel small molecule derivatives improve survivability in cellular model of Huntington’s disease via improving mitochondrial fusion

Key Points

• Mitochondrial dysfunction is critical in the pathology of Huntington's Disease, contributing to cell death.
• The study highlights the role of small molecule derivatives in improving mitochondrial fusion and survivability.
• Improving mitochondrial function through small molecules could offer new treatment strategies for Huntington's Disease.
• Future research may focus on the specific mechanisms by which these derivatives influence mitochondrial dynamics.